Cargando…
Reduction of C-reactive protein and the use of anti-hypertensives
Inflammatory processes are increasingly recognized as important participants in the pathophysiology of hypertension and cardiovascular disease. Angiotensin II may be to a large degree responsible for triggering vascular inflammation by inducing oxidative stress, resulting in up-regulation of inflamm...
Autores principales: | Savoia, Carmine, Schiffrin, Ernesto L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350124/ https://www.ncbi.nlm.nih.gov/pubmed/18200816 |
Ejemplares similares
-
Aldosterone, Inflammation, Immune System, and Hypertension
por: Ferreira, Nathanne S, et al.
Publicado: (2020) -
Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature
por: Schiffrin, Ernesto L
Publicado: (2010) -
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
por: Volpe, Massimo, et al.
Publicado: (2012) -
Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities
por: Kasal, Daniel Arthur B., et al.
Publicado: (2012) -
Hypertension and COVID-19: Current Evidence and Perspectives
por: Gallo, Giovanna, et al.
Publicado: (2022)